Parotid swelling due to Hoshino strain following MMR vaccination in iranian immunization program

来源 :Asian Pacific Journal of Tropical Medicine | 被引量 : 0次 | 上传用户:wsw12345ok
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
This paper reports two seronegative cases of parotid swelling following MMR vaccination,which contains Hoshino strain of mumps virus.This study showed a high,(5%) potential reactogenicity induced by Hoshino strain of current MMR vaccine administered in Iranian EPI.The rate of complication of parotid swelling following national immunization against mumps is more than natural infection.Based on the results of this report, there is the first report of occurrence of parotid swelling 31 days following MMR vaccination.This reaction or complication may not be dependent on the vaccine dose,because one of cases presented parotid swelling following taking one fifth of conventional dose of vaccine.It must be considered this strain may be with high rate of complication and be the subject of change of mumps strain of this vaccine in national immunization program of Iran. This paper reports two seronegative cases of parotid swelling following MMR vaccination, which contains Hoshino strain of mumps virus. This study showed a high, (5%) potential reactogenicity induced by Hoshino strain of current MMR vaccine administered in Iranian EPI. The rate of complication of parotid swelling following national immunization against mumps is more than natural infection.Based on the results of this report, there is the first report of occurrence of parotid swelling 31 days following MMR vaccination. This reaction or complication may not be dependent on the vaccine dose because one of the cases presented parotid resistance following taking one fifth of conventional dose of vaccine.It must be with high rate of complication and be the subject of change of mumps strain of this vaccine in national immunization program of Iran.
其他文献
1病例资料rn患者,男,35岁,2019年5月23日因“咳嗽”于本院综合医疗门诊就诊,医生予盐酸莫西沙星片(德国拜耳公司,规格:0.4g,批号:BJ43488)0.4g,po,qd.首次服用该药30min后,患
采用随机几何方法,分析了有扰的协作自组织网络的性能并给出中继的选择区域. 首先,假设随机网络中的节点服从泊松分布,得到最佳中继选择算法中断概率的闭式解; 其次,给出了此
目的:对程序性死亡受体-1(PD-1)抑制药免疫相关不良反应的文献发表状况进行统计分析.方法:在中国知网(CNKI)《中国学术期刊(网络版)》和科学引文索引数据库(Web of Science)
目的:利用快速卫生技术评估方法,评价托伐普坦治疗心力衰竭的有效性、安全性和经济性,为临床合理用药和医疗机构遴选新药提供循证依据.方法:系统检索PubMed、the Cochrane Li
1病例资料rn患者,女,35岁,因“发现子宫肌瘤4年余”于2019年5月26日入住我院妇产科病区,择期手术治疗.患者既往体健,否认“高血压”“糖尿病”“肾炎”“冠心病”以及肺部疾
目的:探讨吉非替尼致间质性肺病(ILD)的危险因素,为临床安全用药提供参考.方法:检索国内外吉非替尼引起的ILD报道文献共222篇,剔除资料缺失及重复报道的文献,对剩余文献中的
1 病例资料rn1.1 病例1rn患者女,52岁,2019年7月13日以“头痛3月,加重1周”入院,诊断为右侧额叶占位性病变,入院后行右侧额叶占位病变切除术.术后患者发热,体温最高39.5℃.头
目的:对国内已上市的免疫检查点抑制药(ICIs)在肿瘤患者临床使用中的用药安全性进行回顾性研究.方法:收集某肿瘤专科医院2018年7月~2019年7月使用帕博利珠单抗、纳武利尤单抗
目的:对奥美拉唑和兰索拉唑的安全性进行自动监测研究,了解真实世界不良反应发生情况.方法:借助“医疗机构ADE主动监测与智能评估警示系统”调取解放军总医院2016~2017年所有
目的:分析恩替卡韦致不良反应(ADR)发生情况及临床特点,为合理用药提供参考.方法:检索2005年4月~2019年8月CNKI、WainFangData、VIP及PubMed数据库,对收集到的恩替卡韦致ADR文